Sangamo Therapeutics And Pfizer Announce Collaboration For Hemophilia A Gene Therapy – PR Newswire (press release)
Reuters |
Sangamo Therapeutics And Pfizer Announce Collaboration For Hemophilia A Gene Therapy
PR Newswire (press release) "Pfizer has made significant investments in gene therapy over the last few years and we are building an industry-leading expertise in recombinant adeno-associated virus (rAAV) vector design and manufacturing. We believe SB-525 has the potential to be a … Sangamo Therapeutics Reports First Quarter —…–7 Financial Results SANGAMO THERAPEUTICS, INC. (NASDAQ:SGMO) Files An 8-K Results of Operations and Financial Condition Sangamo Therapeutics (SGMO) Receiving Favorable News Coverage, Analysis Shows |
